Singapore markets closed

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
112.46-4.89 (-4.17%)
At close: 04:01PM EDT
112.96 +0.50 (+0.44%)
After hours: 06:42PM EDT

Zimmer Biomet Holdings, Inc.

345 East Main Street
Warsaw, IN 46580
United States
574 373 3121

IndustryMedical Devices
Full-time employees18,000

Key executives

NameTitlePayExercisedYear born
Mr. Ivan TornosCOO, Pres, CEO & Director2.05MN/A1975
Mr. Suketu P. UpadhyayCFO and Exec. VP of Fin., Operations & Supply Chain1.81MN/A1969
Mr. Chad F. PhippsSr. VP, Gen. Counsel & Sec.1.23M2.77M1972
Mr. Sang YiPres of Asia Pacific1.36MN/A1962
Mr. Paul A. StellatoVP, Controller & Chief Accounting OfficerN/AN/A1975
Dr. Nitin Goyal M.D.Chief Science, Technology & Innovation OfficerN/AN/AN/A
Mr. Zeeshan TariqSr. VP & Chief Information OfficerN/AN/AN/A
Ms. Keri P. MattoxSVP and Chief Communications & Admin. OfficerN/AN/AN/A
Ms. Angela MainSr. VP, Global Chief Compliance Officer & Associate Gen. Counsel of Asia PacificN/AN/AN/A
Ms. Lori WinklerSr. VP & Chief HR OfficerN/AN/A1962
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Corporate governance

Zimmer Biomet Holdings, Inc.’s ISS governance QualityScore as of 1 September 2023 is 6. The pillar scores are Audit: 2; Board: 3; Shareholder rights: 4; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.